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Angiographically normal coronary arteries are found in a 
snbstantial number of patients evaluated for angina pecto- 
ris. One third to one half of such patients demonstrate 
abnormalities of myocardial perfusion or metabolism when 
evaluated with invasive techniques. This study was de- 
signed to determine whether angina in such patients is 
attributable to abnormalities of perfusion at rest, maximal 
perfusion or vasodiiator reserve and whether any identified 
abnormalities were global or regional in nature. 
Positron emission tomography was performed with ox- 
ygen-Wabeled water (f&%) and oxygen-15-labeled car- 
bon monoxide (C%) before and after iutravenous dipy 
ridamole to assess regional myocardial perfusion and 
perfusion reserve in absolute terms in 16 normal subjects 
and 17 patients with chest pain and angiographically nor- 
mal coronary arteries. Eight of the 17 patients had a 
myocardial perfusion reserve <2.§ (the lower limit of 
normal in st with positron emission t 
well as with techniques) and 9 of 17 
normal response. In the patients wit& an im 
sioa reserve, perfusion at rest was signilantly higher tban 
that measured in normal subjects ( 
f 0.28 ml/g per min, p C 0.02) 
perfusion reserve were siguificantl 
versus 4.62 f 1.5g mpg 
1.1, respectively; p < 0. 
malities of perfusion a 
homogeneous without detectable regional disparities. 
Thus, nearly haffof patients with chest pain and normal 
coronary arteries have abnormalities of myocardial perfu- 
sion that are detectable noninvasive$y withpositron emis- 
sion to hy an **so. 
(9 Am Coil Card&d ~99~;~~:5~~-9S~ 
Angiographically normal epicardial coronary arteries are 
seen in a substantial subset of patients evaluated for angina 
pectoris. Despite their low mortality rate, some patients 
experience frequent episodes of severe chest pain, precipi- 
tating repeated and extensive medical evaluations. When left 
ventricular hypertrophy is present, angina may reflect in- 
creased wall stress, intramyocardial deposition of collagen 
that limits access of myocytes to substrates and oxygen or 
impaired subendocardial perfusion. However, in most pa- 
tients with chest pain and angiographically normal coronary 
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arteries, ventricular mass is normal. When pain is not 
associated with mitral valve prolapse, myocardial coronary 
bridging or noncardiac processes ( uch as musculoskeletal 
abnormalities, costochondritis, e ophageal dysmotility and 
psychosomatic disorders), the pain has been attributed to 
microvascular bnormalities (I-6). In some patients, in- 
creases in great cardiac vein blood flow are limited in 
response to cardiac pacing or dipyridamole (1,3,5). Micro- 
vascular spasm has been implicated in some patients by 
observed attenuation of the increase in great cardiac vein 
flow induced by pacing or dipyridamole after infusion of 
ergonovine (4,6). 
Despite these intriguing and suggestive observations, the 
pathogenesis of angina with normal coronary arteries has 
remained somewhat controversial. Coronary sinus or great 
cardiac vein flow may not reflect nutritive perfusion for 
several reasons, including its inability to distinguish regional 
alterations in flow. Increases appear to underestimate coro- 
nary flow reserve. Great cardiac vein flow increases only 
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in the ventricle as a whole. 
al coronary arterio- 
isease were selected by 
rams were considered normal 
Patients with a history of asthma, obstructive pulmonary 
disease or an allergic response to dipyridamole, aspirin or 
nonsteroid anti-inflammatory d ugs were excluded. Those 
with documented vasospasm of epicardial coronary vessels 
occurring spontaneously or in response to ergonovine were 
also excluded. Patients were included only if they reported a 
history of chest pain highly suggestive of angina pectoris 
(that is, exercise-induced, relieved by nitrates or associated 
with an abnormal exercise lectrocardiographic [ECGI or 
scintigraphic response). Seventeen patients were studied 
comprising 13 men and 4 women 40 to 73 years of age (mean 
2 SD 53 + 10). Their clinical characteristics are delineated 
these normal subjects was reported pre 
our initial validation studies. Each bad had no symptoms 
suggestive of heart disease. Physical examination and the 
rest ECG were normal in each. The normal volunteers 
ces can attenuate  
After collection of attenuati 
saline solution. List mode data were collected be~~~fli~~ 
with the onset ofinjection for 150 s. After a5 min interval to 
allow for decay of tracer activity to baseline l vels, 40 to 50 
mCi of oxygen-l5-labeled carbon monoxide (C%) was 
administered by inhalation to label the blood pool. After a 
brief delay to allow residual tracer to clear from the lungs, 
data were collected for 5 min. After collection f baseline 
data was complete, 0.14 mgkg per min, dipyridamole (Per- 
santine, Boehringer-lngelheim) wasadministered intrave- 
nously for 4 min (0.56 mglkg total dose) with a calibrated 
infusion pump. After an interval of 4 to 
completion of the infusion to permit su 
occurrpnce ofthe peak ow response, the i 
was repeated after epeat administration o 
The ECG was monitored continuous 
procedure. Serial seven lead 
anterior precordial lead) acre recorded at baseline, before 
and after the first imaging sequence, at the initiation Of the 
infusion of dipyridamole and every 2 min thereafter until 
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Table 1. Demographic and Clinical Characteristics of the Patients S udied 
Case Age (yr)l Chest Chest Pain With Angiograpbic 
No. Gender Pain HTN LVH ECG ET-T TI-201 Medication Dipyridamole LVEF Coronary Disease 
Patients With Normal Myocardial Perfusion Reserve (Group I) 
- 0.63 None 
- 0.83 None 
+ 0.12 40% LAD 
t 0.61 20%30% LCx 
0.1 I
t 0.80 
t 0.65 
None 
None 
None 
0.60 RCA PLQ 
0.74 LAD PLQ 
NL 
t t NL 
t - LBBB 
t - NL 
t - NT 
- NST 
NL 
- NL 
t - NSTT 
Nit 50/M 
641M 
56/F 
R 
TNG 
EX 
R 
Ex 
R 
TNG 
Ex 
R 
TNG 
Ex 
R 
R 
TNG 
Ex 
R 
TNG 
Ex 
R 
Ex 
R 
BB 
HCTZ 
Nit 
Ver 
UI t 
CP 
Dilt 
BB 
52/M t 
CP 
4 
Nit 
Dilt 
0 
S2lF 
42/M 
58/M 
0 0 
0 0 
0 Dilt 
CP Nit 
8 
9 
40/M 
73/M 
0 0 0 
Ver t 0 
Patients With Reduced Myocardial Perfusion Reserve (Group II) 
0.81 None 
t 0.63 None 
0.12 
t 0.53 
None 
PLQ LAD 
PLQ LCx 
0.74 
0.68 
+ 0.12 
PLQ LAD 
PLQ LCx 
PLQ RCA 
None 
t 0 Dilt t 0.65 
PLQ LAD 
PLQ LCx 
PLQ RCA 
None 
IO 59/M Ex 
R 
TNG 
Ex 
R 
TNG 
Ex 
Ex 
R 
TNG 
R 
t 
t - 
NL 
NT 
NL 
NL 
NL 
PRWP 
Paced 
PRWP 
0 Dig 
Nit 
II 41/M 0 0 Nit 
Dilt 
I2 43/M 
I3 45/F 
t 0 
0 0 
0 
0 
I4 7IIM + Dilt 
Nif 
Nit 
0 IS 
16 
50/M 
63/M 
Ex 
R 
Ex 
TNG 
t + 
0 0 Nil 
Fur 
I7 49/F Ex 
R 
TNG 
BB = beta-adrenergic blocker; CP = chest pain: Dill = diltiazem: ECG = electrocardiography: ETT = exercise tolerance lest: Ex = exercise: F = female: 
Fur = furosemide: HCTZ = hydrochlorothiaeide: HTN = hypertension: LAD = left anterior descending coronary artery: LBBB = left bundle branch block; 
LCx = left circumflex coronary artery: LVEF = left ventricular ejection fraction: LVH = left ventricular hypertrophy: M = male: Nif = nifedipine; Nit = 
long-acting nitrates: NL = normal; NST = nonspecific ST segment abnormalities: NSIT = nonspecific ST-T wave abnormalities; NT = nonspecific T wave 
abnormalities: PLQ = minor plaquing or luminal irregularity t<20% stenosis): PRWP = poor precordial R wave progression: R = angina at rest: RCA = right 
coronary artery: TI-201 = thallium-201 scintigraphy: TNG = pain relieved by nitrates: UI = uninterpretable: Ver = verapamil: 0 = not performed; + = positive 
findings: - = negative (normal) findings. 
termination f the second C”0 data collection study. If the 
Patient developed symptoms, an additional ECG was re- 
corded until symptoms had abated and the ECG had re- 
turned to baseline. Blood pressure was monitored with a 
sphygmomanometer at 1 min intervals during the infusion f 
dipyridamole and at 2 min intervals during imaging. 
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reconstruction corn 
graphic sections. Each 
a 828 X 128 matrix ofvoxels, each 
tial 2 s frames. A 3 X 3 voxel region of interest was 
positioned interactively in the ce ter of the left atrial blood 
pool and decay-corrected counts for t 
d were plotted for the first 30 s 
The time of arrival of tbe bolu 
pool was determine 
ning with the time of arrival of radioactivity 
left atrial blood, a single composite image was 
from 120 s of data for each ventricular level. 
ite H,‘50 images, radioactivity att~~b~tab~e to 
tracer in the cardiac blood pool was corrected on a pixel by 
pixel basis as previously described (I l-13). The co 
spillover-corrected images were employed for posit 
regions of interest in left ventricular myocardium. 
use of an interactive cursor, a 3 X 3 voxel regio 
was centered in the left atrial blood pool for dete 
the arterial input function Larger irregular regi 
est were placed over the septum and anterior, lateral and 
posterior wall at multiple levels for determination of tissue 
time-activity curves. 
Ca~c~~a~i~n of myoca . For calculation of 
myocardial perfusion in , data were reformat- 
ted into a sequence of 18 consecutive 5 s tomographic 
reconstructions. Regional, nutritive myocardial blood flow 
at rest and after dipyridamole injection was determined in 
absolute terms with a kinetic modification of the Kety one 
compartment model as previously described and validated in 
our laboratory (9,141. The method requires knowledge of the 
arterial input function, the time-activity curve of the flow 
in the myocardiu and the tissue/blood partition 
ient for the tracer. evious studies in our laboratory 
(9) have demonstrated that time-activity curves obtained 
from regions placed in the left atrial blood pool closely 
approximate arterial input functions measured directly. 
The model aswmes thut the nrterid input firnctiorl is tlol 
at levels above an 
ness, with their una 
ow at rest in the same region of interest. 
be significant. 
aged 53 + 10 years. On coronary angiog 
irregularities or plaquing was observed 
tients. Two additional patients each demonstrated a single, 
subcritical coronary lesion demonstrating luminal narrow- 
ings of 20% to 40% of the vessel diameter. Thirty-five 
percent had a history of hypertension, but no subject had 
ECG evidence of left ventricular hypertrophy and only one 
had mild left ventricular hypcrtrophy noted at left ventricu- 
lography. seven percent bad an abnormal rest KG, 
including cific ST-T wave abnormalities in four, 
precordia wave transition in two, left bundle branch 
in one and a permanent pacemaker in one patient. Seventy- 
six percent were taking one or more antianginal medications. 
Eight of the 17 patients had typical angina cbaracter~zed as 
exertional substernal chest pain sometimes relieved by ni- 
trates. Six other patients had exercise-induced chest pain not 
promptly relieved by nitrates. Atypical features were seen in 
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Table 2. Hcmodynamics at Rest and After Dipyridamole 
Rest Dipyridamole 
HR SBP DBP MAP MBF HR SBP DBP MAP MBF 
Case No. (beatshin) (torr) (tom) (torr) (ml/g per min) (beats/min) (torr) Uorr) (torr) (ml/g per min) MPR 
Patients With Normal Myocardial Perfusion Reserve (Group 1) 
1 56 119 80 93 1.12 76 120 79 93 3.69 3.2 
2 52 123 85 98 0.86 66 I21 a2 95 2.55 3.0 
3 68 140 72 95 I .03 94 131 68 89 5.98 5.8 
4 73 140 93 109 0.85 107 141 89 106 4.13 4.9 
5 62 127 80 % 0.46 76 I24 74 91 3.28 7.1 
6 60 133 83 100 1.84 85 144 83 103 8.35 4.5 
7 62 124 83 97 1.56 % 126 77 93 6.15 3.9 
8 77 112 69 83 1.71 100 123 69 87 7.03 4.1 
9 55 153 86 108 1.07 57 152 86 108 3.21 3.0 
:- 
Patients With Reduced Myocardial Perfusion Reserve Group II) 
-- 
10 51 173 89 116 I.92 63 165 78 106 2.21 ;.:1 
II 70 115 75 88 1.49 87 II5 72 86 3.59 2.4 
12 70 I28 90 to3 1.50 81 I:1 93 109 1.81 1.2 
13 87 101 67 78 I .43 99 111 68 a2 2.20 1.5 
14 62 114 50 71 I .92 71 89 40 56 1.22 0.6 
15 72 142 75 97 0.88 87 145 82 i03 0.87 1.0 
16 60 154 IO2 119 1.54 78 149 98 115 2.73 1.8 
17 85 135 89 104 2.23 95 118 81 93 3.48 1.6 
-. 
Combined Results for All Patients 
Normal subjects 69 ? 11 Ill+10 7326 8526 1.25 I 0.28 94214 118~12 6827 8525 4.62 i 1.58 3.8 + I.1 
All patients 65+ 11 132 i: 16* 80 + 12) 97 2 13* 1.38 + 0.46 83 + 14 135 + 20, 78 f 13t 95 + 14t 3.68 t 2.01 3.0 i: 1.8 
Group I 63 + 8 130 2 13* 81 + 7t 98 f 8* 1.17 * 0.43$ 85 r 15 131 2 12* 79 + 7* % + 7’ 4.93 r 1.891 4.4 + I.35 
Group Ii 702 12 133 2 24* 80 f 6 97 + 17t 1.61 + 0.38t 83 + 12 129 f 25 77 2 18 93 + 19 2.26 ZIZ 0.92* 1.4 + OS* 
*p < 0.01 versus normal: tp < 0.05 versus normal: Sp < 0.05 versus Group II: Jip < 0.01 versus Group II. DBP = diastolic blood pressure: HR = heart rate; 
MAP = mean arterial pressure; MBF = myocardial blood flow: MPR = myocardial perfusion reserve: SBP = systolic blood pressure. 
many patients, including occasional chest pain at rest or 
atypical radiation ofpain. Five patients had been admitted to 
the coronary care unit for the evaluation ofsevere chest pain 
on at least one occasion. Exercise ECGs or exercise thallium 
scintigrams were abnormal in7 of the 10 patients in whom 
these tests were performed. 
The mean time of coronary angiography to positron 
emission tomography was 79 days (range 1 day to 1 year). 
Eight patients were studied tomographically within 48 h of 
catheterization. There were no major clinical events be- 
tween catheterization and tomography in any patient, with 
one exception. Patient 16 had a long history of syncopal 
episodes and had a permanent pacemaker in place. A single 
syncopal episode occurred between cardiac atheterization 
and his initial tomographic study, but there were no sequelae 
of this event and no evidence of interim myocardial infarc- 
tion. The patient was studied tomographically on a second 
occasion 4 months after his initial study, without asignificant 
interim event and without a significant change in tomo- 
graphic findings. 
Hemodynatnic and clinical responses to dipyridamole (Ta- 
ble 2). The interval from initiation of infusion of dipyrida- 
mole to injection of H,“O was 8.5 ? 0.7 min in normal 
control subjects and 9.0 ? 1.3 min in patients (p = NS). In 
the normal subjects, heart rate increased from 69 + 11 to 94 
+ 14 beatslmin (p< 0.001) accompanied bya slight increase 
in systolic and mean blood pressure and a slight decline in 
diastolic blood pressure. Inthe patients, heart rate increased 
from 65 + 11 to 83 + 14 beatslmin. Neither systolic nor 
diastolic pressure changed significantly. However, rest and 
postdipyridamole b ood pressures were significantly higher 
in patients than in normal subjects under the same condi- 
tions. Nine patients experienced chest pain during or after 
infusion of dipyridamole; in each, the pain was similar to that 
experienced spontaneously. Five of the nine patients exhib- 
ited reversible ST segment depression with infusion of 
dipyridamole, but ST segment depression was ~0.1 mV in 
all. 
For purposes of data analysis, all patients were com- 
pared with all normal volunteers. In addition, patients were 
separated into two groups with respect o estimates of 
myocardial perfusion reserve. One group (Group I) com- 
prised patients in whom myocardial pet&ion increased 
22.5fold (a normal response, based on our experience [9] 
JACC Vol. 16. No. 3 
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with normal subjects stu 
probes). The other gro 
those in whom the re 
heart rate after dipyridamole averaged IP +- 3 beats/min in 
patients in Group II pared with 25 2 7 
normal subjects (p < 0. ) and 22 k 8 beats/m 
with chest pain, ang~o~ra~hical~y normal core 
and normal flow respons 
responses of systolic and 
ridamole were similar in the two groups of patients (ihat is, 
those with normal and those with atte 
myocardial perfusion to dipyridamole). 
work loads reflected by the rate-pressure product (heart rate 
x systolic blood pressure) induced by di~yridamo~e were 
similar in normal subjects and both groups of patients. The 
proportion of men and the characteristics of the chest pain 
were similar in the two groups of patients. as was the 
incidence of induction of chest pain with dipyridamole 
yocardial perfusion. Patients differed from normal sub- 
respect to myocardial nutritive perfusion at rest 
and after dipyridamole and with respect to calculated myo- 
cardial perfusion reserve (Table 2. Fig. 2). At rest. myocar- 
dial perfusion in normal subjects averaged 1 
per min; it increased to 4.62 2 I .58 ml/g per 
after dipyridamole. Average myocardial perfusion reserve 
was 3.6 z 1.1. With all 17 patients considered as a group. 
blood flow at rest was higher ( I .3& + 0.46 ml/g per min) and 
maximal myocardial blood flow lower (3.68 ? 2.02 ml/g per 
min) than In normal subjects. Although these differences 
were not significant, they were directionally consistent. 
Average data for myocardial perfusion reserve ( 
ew bar), all patients (n = 17) (s 
in Group I. perfusion reserve z2.5, (n = 9) 
ad and patients in Gro 
reserve c2.5. in = 8) (s! 
II, mpcardial pet&ion 
bW). sekets in andard 
eviations and the asteris isares < 0.001 d with 
ormal subjects or with pa with normal myoc r&ion 
resci‘ve. 
onses delineated previ- 
8 of the 17 patients 
sion reserve (C2.5) i 
contrast to only 2 of 16 normal volu 
c&square analysis) (Fig. 1). Striking d 
parent in comparisons of patients in Groups 
flow st in patients in Group II av 
CO111 with 1.25 + 0.28 ml/g per mi 
(P < and 1.17 * 0.42 ml/g per 
I (p < 0.05) (‘fable 2). 
markedly lower (2.26 
Croup II compared with values m 
I38 ml/g per min. p = 0.001) and patients in Group I (4.93 2 
I .89 ml/g per min. p = 0.004). Myocardial perfusion reserve 
in patients in Group 11 averaged only 1.4 ? 0.5 compared 
with 3.8 +- 1.1 in normal subjects (p c 0. 
in Group 1 (p < 0.001). 
Myocardial perfusion reserve in patients in whom chest 
pain was induced by dipyridamole was nol significantly 
different from values in patients in whom it was not (3.0 fr 
I.7 versus 2.9 + 2.0. p = IS). ‘The percent of patients in 
Groups I and 11 with abnormal treadmill or thallium scinti- 
graphic studies was comparable (Table 1). Myocardial per- 
fusion reserve in patients with a ositive trea~mili or thal- 
lium exercise stress test was not significantly di@ercnt from 
that in those in whom results of these tests were normal (2.6 
I 2.0 versus 3.3 ‘_ 1.7. p = NS). The prevalence of minor 
irregularities of the coronary vasculature was si 
Groups I and II, and the presence of plaquing did not aflect 
rest or maximal myocardial blood fiow or myocardial perfu- 
sion reserve. Myocardial perfusion reserve in patients with 
592 GELTMAN ET AL. 
ANGINA AND NORMAL CORONARY ARTERIES 
JACC Vol. 16, No. 3 
September 1990:586.-95 
coronary artery plaquing was 3. l * 1.9 compared with 2.9 + 
1.9 (p = NS) in patients without coronary lumina! irregular- 
ities. 
Nearly half of the patients in each of the two groups had 
been given nitrates recently, and half of those in each group 
had been given a calcium channel blocker. There was no 
significant difference in per&ion at rest between patients 
with and without calcium channel blockade (1.35 f 0.55 
versus 1.40 2 0.41 mYg per min, p = NS), and there was no 
difference inmaxima1 perfusion (3.75 + 1.54 versus 3.59 2 
2.67 ml/g per min) or in myocardial perfusion reserve (3.5 2 
2.2 versus 2.3 -C 1.2, p = NS). These data suggest that 
patients had indeed not taken their medication during the 12 
to 18 h before tomography asinstructed or that hese agents 
did not significantly affect he variables assessed. Recent 
work by Rossen et al. 121) demonstrated that reatment with 
diltiazem did not alter coronary flow reserve measured with 
an intracoronary Doppler flow probe in a group of patients 
undergoing diagnostic ardiac catheterization. Similarly, 
there were no differences in rest or maximal myocardial 
blood flow or myocardial perfusion reserve between patients 
who had or had not been receiving long-term nitrate therapy. 
Overall left ventricular function was comparable b tween 
patients in Groups 1and II (Table 1). 
Old rises.. Myocardial perfusion was ho- 
mogeneous in normal subjects and patients. Nodiscrete per- 
fusion defects were apparent on composite omographic im- 
ages (Fig. 3). When myocardial perfusion was assessed 
1Figure 5. Midventricular reconstruc- 
tions depicting relative Bow for a 
normal subject 0?300), Patient B 
(B473) from Group II with reduced 
myocardial perfusion reserve 
and Patient 9 (P571) from G ! 
with normal myocardial perfusion re- 
serve. Values for perfusion rese 
are shown above ach image. The 
of each image is anterior and the 
of each image is the patient’s 
of highest flow and areas of blue and 
Mark signify lowest flow. In each 
image, the discontinuity posteriorly 
is due to the mitral pparatus, which 
is below the resolution of the instru- 
ment. In each patient, subjective and 
objective assessmeca indicated that 
myocardial perfusion was homoge- 
neous despite wide differences in 
myocardial perfusion reserve among 
the patients. Thus, simple static im- 
aging of relative perfusion does not 
permit assessment of quantitative dif- 
ferences in myocardial perfusion or 
perfusion reserve. 
regionally in three to four regions per tomographic reconstruc- 
tion, responses were relatively unifo within each subject and 
patient (Fig. 4). The coefficients of variation for myocardial 
perfusion with hyperemia were 26 2 17 for normal subjects, 22 
2 15 for patients inGroup II with reduced myocardial perfu- 
sion reserve and 14 +10 for the patients inGroup I with normal 
myocardial pefision reserve (p = NS). No systematic diier- 
ences in perfusion were noted among anterjor, septal, ateral 
and posterior regions with regard to rest flow, peak flow or 
myocardial perfusion reserve in normal subjects or either 
group of patients (Fig. 4). 
Reproducibility of Row es. To define the reproduc- 
ibility of the tomographic end points and the persistence of 
impaired perfusion over time, 10 patients were studied on 
two occasions an average of5.2 months apart (range 3h to 10 
months). No significant differences were observed between 
results of initial and follow-up studies with regard toperfu- 
sion at rest or after dipyridamole or with regard to myocar- 
dial perfusion reserve. Initial and repeat measurements of 
perfusion correlated closely (r = 0.93, p < 0.001) (Fig. 5). 
Myocardial perfusion reserve. Our results indicate that 
myocardial perfusion reserve is limite in a s~bsta~ti~~ 
number of patients with chest pain and angiographically 
normal coronary arteries. The limitation of perfusion reserve 
reflects both increased flow at rest and decreased maximal 
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$ 7.0 
9 6.0 
z 5.0 
4.0 
3.0 
2.0 
1.0 
0.0 
S A L SA L 
, Regional values of myocardial perfusion at rest and after 
dipyridamole fornormal mu (top), patients in Croup 
and patients in Group II ie). No regional disparities were 
observed. A = anterior; L = lateral; S = septum. 
yocardial ~e~~sio~ induced the vasodilator dipyrida- 
mole. These abno sion appear to be global, 
throughout the left ventricle. Thus, variability of regional 
Figure 5. Myocardial b ood flow (MBF) was assessed twice at rest 
or with dipyridamole stress, or both, in 10 patients. Data cquired at
rest are indicated by solid circles and those acquired after dipyrida- 
mole by open circles. Results of the duplicate studies correlated 
closely. 
OBSERVATON 1 
ion constant level. 
eart of intact a 
perfusion i duced by di~yridamo~e. Reduced maximal myo- 
cardial perfusion and reduced myocardial perfusion r 
were evident in 8 (47%) of the 17 patients we 
Patients with reduced maximal myocardial perfusion and 
perfusion reserve were indistinguishable from those patients 
with normal perfusion reserve based on gender, clinical 
history, characteristics of the chest pain, rest hemodynamics 
(heart rate, systolic blood pressure, ate-pressure product), 
to dipy~damole or exercise tress a
ients in both Groups 
nteers, but there w 
ence in age between patients i  Groups Yand 
preliminary studies in our iaboratory (u 
tions), myocardial erfusion at rest and 
healthy subjects >40 years of age without evidence or 
history of heart disease appeared to be compar 
those of younger individuals. The minor degrees ofcoronary 
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atherosclerosis observed in some patients in this study did 
not appear to affect the results ubstantially because myo- 
cardial perfusion at rest and perfusion reserve in patients 
with minor degrees ofplaquing were comparable with those 
in patients who did not demonstrate such luminal irregular- 
ities. Despite some overlap, increases in heart rate induced 
by dipyridamole w re fess in patients with depressed myo- 
cardial perfusion reserve compared with changes inthe other 
patients or in normal volunteers. Visual assessment of
tomographic images of relative perfusion did not permit 
differentiation f patients with and without blunted re- 
sponses to dipyridamole. 
Previous studies. Our observations are concordant with 
prior observations by others who employed invasive tech- 
niques. Opherk et al. (5) studied 36 patients with chest pain 
and normal coronary arteriograms and demonstrated re- 
duced coronary sinus blood flow reserve in 21, most of 
whom had episodes of severe chest pain and abnormai 
exercise stress tests. Observations by Cannon et al. (II 
demonstrated attenuation f the increase in great cardiac 
vein flow induced by rapid atrial pacing in I3 (59%) of 22 
patients, with relative preservation of the response in the 
remainder despite similar presenting symptoms. 
Metabolic studies in patients with chest pain and angio- 
graphically normal roronary arteries have been pefirmed by 
several investigators (I ,3.5,29) employing great cardiac vein or 
coronary sinus catheterization. Abnormal f ow or metabolic 
responses were found in 34% to 46% of patients with chest pain 
and angiographically normal coronary arteries. 
Wail motion at rest was normal in ollr patients and those 
studied by Cannon et al. 124). However, they observed focal 
wall motion abnormalities after exercise stress in 46% of 
patients and other abnormalities of global or regional ejec- 
tion fraction i 79% of patients undergoing exercise stress. 
Conversely, although Picano et al. (25) observed ST segment 
depression i 84% of patients tudied after high doses of 
intravenous dipyridamole, no wall motion abnormalities 
were detected. 
Thallium scintigraphy has been employed extensively in 
the diagnostic evaluation of patients with chest pain and 
angiographically normal coronary arteries. Abnormalities 
have been observed inthe regional distribution rkinetics of 
thallium-201 after exercise in15% to 45% elf patients (22,23). 
The limitation of myocardial per&ion reserve observed 
in the present study was remarkably homogeneous. Regional 
information is not available from the analysis of coronary 
sinus or great cardiac vein flow by catheterization. Wall 
motion abnormalities have been found in 0% to 79% of 
patients with angina and angiographically normal coronary 
arteries (X25,30) and regional bnormalities of the distribu- 
tion of thallium-201 in 15% to 45% (22,23). The low incidence 
of regional abnormalities of myocardial perfusion reserve 
okmd in our study is consistent with observations by 
Picano et al. (251, who used dipyridamole (as did we), an 
intervention that accentuates regional d
sion without necessarily inducing isch 
most studies (22-24) reporting a high incidence of regional 
wall motion or thallittm distribution a~~~rrna~~t~~s are those 
in which exercise stress was employed. 
Technical considerations. Positron emission tomography 
provides quantification of regional tissue content of tracer 
not attainable with single photon imaging tech 
ing single photon emission computed tomogr 
l5-labeled water behaves essentially as a freely 
tracer in the heart and permits accurate measurement of 
myocardial perfusion despite hyperemia (9,1 l-14). 
The tomographic data in the present study were acquired 
in ;m ungated mode. Thus, significant spatial averaging was 
unavoidable (19). Although ECG gating is feasible with 
positron emission tomography and has been employed in 
some studies (19.311, its implementation with dynamic ac- 
quisitions including individual time frames as brief as 5 s is 
impractical because of limitations in counting statistics. 
Because of the lack of gating and because of volume aver- 
aging, small regional abnormalities of myocardial pe 
might have been missed, particularly if they iavol 
inferoposterior wall or apex, regions with data most 
distortion from partial volume averaging. Perfusion abnor- 
malities observed in other patients may have involved pri- 
marily subendocardium. Unfortunately, the spatial resolu- 
tion of current generation positron emission tomographic 
instruments does not permit independent assessment of
subendocardial and subepicardial perfusion. 
Ajixed dose of dipyridamoie (0.56 mglkg) was used in our 
study. Previous studies (8,321 with coronary artery Doppler 
catheterization have demonstrated that the coronary blood 
flow response to dipyridamole is variable. Some patients 
respond to only large doses of dipyridamole. Dipyridamole 
may not elicit maximal coronary vasodilation compared with 
that induced by papaverine (10.32). 
Clinical implications. The data obtained indicate t
many patients with chest pain and angiographically normal 
coronary arteries exhibit limited nutritive perfusion reserve. 
The limitation of perfusion reserve is detectable noninva- 
sively. Its response to putative therapeutic ntervention 
should facilitate objective valuation of benefit without he 
need for repeated cardiac atheterization and ultimately help 
to clarify the nature of the fundamental derangement respon- 
sible for the syndrome. 
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